Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C ...
News Release 18-Sep-2021 Adjuvant immunotherapy prolongs recurrence-free survival in resected stage II B/C melanoma ESMO Congress 2021, 16-21 ...